Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1088.5000 4.60 (0.42%)
NSE Oct 01, 2025 13:45 PM
Volume: 589.3K
 

1088.50
0.42%
BOB Capital Markets Ltd.
Eugia unit 3 capacity utilization to increase to 60-65% from 50% in Q3FY25. We expect capacity utilisation to rise above 70% in FY26E
Aurobindo Pharma Ltd. is trading below its 100 day SMA of 1118.6
More from Aurobindo Pharma Ltd.
Recommended